Journal of ArrhythmiaAPHRS & JHRS

Iatrogenic Atrial Septal Defects After Transseptal Puncture

Iatrogenic atrial septal defects after transseptal puncture are a frequent structural consequence of left atrial access. They arise when a needle, dilator, or large sheath crosses the interatrial septum during electrophysiology procedures, most commonly catheter ablation for atrial fibrillation. In many patients, the resulting opening is small, produces a clinically insignificant left-to-right shunt, and closes spontaneously.

Clinical importance depends on more than the presence of a residual defect. Its diameter, tunnel-like anatomy, flow direction, duration, and the patient’s right- and left-sided filling pressures all influence risk. A small communication may become relevant when pulmonary hypertension, right ventricular dysfunction, tricuspid regurgitation, respiratory disease, or venous thromboembolism changes the pressure gradient across the septum.

Incidence estimates vary because studies use different imaging schedules and definitions of persistence. Early echocardiography detects more defects than late follow-up, while larger sheaths and repeated septal crossings tend to produce more durable communications. Understanding these distinctions helps clinicians avoid both unnecessary alarm and inadequate surveillance.

How Transseptal Access Creates Atrial Defects

The fossa ovalis is the preferred target for transseptal puncture because it is relatively thin and usually provides a predictable route into the left atrium. After the needle crosses, the dilator and sheath enlarge the tract. Tissue recoil and the flap-valve configuration of the septum often reduce flow once the sheath is removed, but the opening may remain patent for weeks or months.

Procedural technique affects the final anatomy. A single puncture with a modest-diameter sheath generally causes less tissue disruption than repeated access, exchange of large sheaths, or use of steerable systems. Cryoballoon ablation, pulsed-field ablation, left atrial appendage occlusion, and structural interventions may require larger or more manipulated transseptal equipment than conventional radiofrequency ablation.

The septum can also be distorted by prior surgery, congenital heart disease, device implantation, or an existing patent foramen ovale. These conditions may complicate localization and increase the chance of an atypical puncture site. Detailed three-dimensional imaging and electroanatomic guidance can be particularly helpful in complex anatomy, as illustrated by work on scar-related atrial tachycardia mapping.

Incidence And Persistence Over Time

Reported acute iatrogenic atrial septal defect rates after transseptal electrophysiology procedures commonly fall within the 5% to 20% range, although some cohorts report lower or higher values. The broad range reflects differences in sheath size, imaging modality, timing of assessment, number of punctures, and whether a tiny color-Doppler jet is counted as a defect.

Most early defects become smaller or disappear during follow-up. Persistent defects at six to twelve months are generally reported in a low single-digit percentage of patients after standard atrial fibrillation ablation. Persistence appears more frequent when large-bore equipment is used, when the septum is punctured repeatedly, or when the access tract is positioned away from the ideal central fossa ovalis.

Cryoballoon procedures have received particular attention because the balloon catheter often requires a larger transseptal sheath. Some studies have found a higher early residual defect rate after cryoballoon ablation than after radiofrequency ablation, while differences in long-term persistence are less consistent. These findings support individualized follow-up rather than assuming that every residual opening has the same prognosis.

Imaging timing is essential when interpreting incidence. A defect identified the day after a procedure may represent a transient puncture tract that will close naturally. A communication documented repeatedly at later examinations, especially with measurable shunt flow or right-heart enlargement, has a different clinical meaning.

Hemodynamic And Clinical Significance

The usual pressure gradient after left atrial access favors left-to-right flow. This direction generally prevents systemic embolization and may produce no symptoms. Small shunts are often discovered incidentally during transthoracic echocardiography, transesophageal echocardiography, or intracardiac imaging performed for another reason.

Right-to-left shunting is less common but more concerning. It may occur transiently during coughing, Valsalva strain, mechanical ventilation, or acute rises in right atrial pressure. Persistent right-to-left flow can develop with pulmonary hypertension, severe right ventricular failure, significant tricuspid regurgitation, or a large defect. Potential consequences include arterial desaturation, platypnea-orthodeoxia, and paradoxical embolism.

A clinically important left-to-right shunt may contribute to right atrial and right ventricular volume overload, although this is unusual with small post-puncture defects. Symptoms such as unexplained dyspnea, reduced exercise tolerance, hypoxemia, recurrent embolic events, or new right-heart dilation should prompt a more detailed assessment rather than attribution to the ablation procedure alone.

The presence of a defect does not automatically explain postprocedural symptoms. Recurrence of atrial fibrillation, pulmonary vein stenosis, pericardial disease, heart failure, lung disease, and pulmonary vascular pathology may be more relevant. The defect should be interpreted within the complete clinical and hemodynamic context.

Factors That Influence Risk

Several procedural and patient-related characteristics are associated with a higher likelihood of persistent iatrogenic shunting:

Anticoagulation requires particular care. A small left-to-right defect does not generally require a new antithrombotic strategy, and routine closure is not indicated solely to prevent stroke. The patient’s underlying atrial fibrillation, cardioversion status, left atrial thrombus risk, and procedural protocol should guide anticoagulation decisions.

Implanted cardiac devices may complicate the broader assessment of embolic or hypoxemic events. Device follow-up remains important when a patient undergoes repeated interventions or develops unexplained symptoms; resources addressing lead integrity surveillance provide a reminder that device-related findings must be separated from septal-access complications.

Imaging And Diagnostic Assessment

Transthoracic echocardiography is a practical first test, particularly when there is right-heart enlargement, hypoxemia, or a new murmur. Color Doppler may show a left-to-right jet, but a very small tract can be missed. Agitated-saline contrast is useful for detecting right-to-left passage, especially when performed with Valsalva or another maneuver that transiently raises right atrial pressure.

Transesophageal echocardiography offers better visualization of the interatrial septum and can define defect location, size, rims, tunnel morphology, and flow direction. It is valuable when closure is being considered or when transthoracic findings are inconclusive. Intracardiac echocardiography may identify the defect during a repeat electrophysiology procedure and can support real-time hemodynamic evaluation.

Cardiac magnetic resonance imaging or computed tomography may be appropriate when the anatomy is complex or when quantification of pulmonary-to-systemic flow is needed. Right-heart catheterization is reserved for selected cases involving suspected pulmonary hypertension, significant shunting, unexplained hypoxemia, or discordance between symptoms and noninvasive imaging.

A useful diagnostic report should document more than “ASD present.” It should describe the defect’s maximal dimensions, shunt direction, estimated hemodynamic effect, right-heart size and function, pulmonary pressure estimate, and whether there is evidence of thrombus or other structural disease.

When Observation Is Appropriate

Most small iatrogenic defects can be observed. A patient with no hypoxemia, no embolic event, no meaningful right-heart enlargement, and a small left-to-right shunt usually needs clinical follow-up and repeat imaging rather than immediate intervention. The interval depends on the initial size, symptoms, comorbidities, and type of procedure.

Closure may be considered when the defect remains sizeable and produces a significant left-to-right shunt, causes right-heart volume overload, or is associated with clinically important right-to-left flow. Recurrent paradoxical embolism, persistent oxygen desaturation, or severe positional symptoms may strengthen the case for intervention after other causes have been excluded.

Percutaneous closure is technically feasible in selected patients, but it carries its own risks, including device embolization, erosion, arrhythmia, thrombus formation, interference with neighboring structures, and difficulty with future left atrial access. Timing also matters: early closure can be challenging when the margins are friable or the tract is still evolving.

The decision should be multidisciplinary when symptoms are substantial or anatomy is unusual. Electrophysiologists, structural heart specialists, imaging experts, and congenital cardiologists can weigh shunt magnitude against procedural risk and future access needs.

Clinical setting Typical interpretation Usual approach
Small early left-to-right jet, no symptoms Likely transient access tract Observation and clinical follow-up
Persistent small defect without right-heart effects Low immediate hemodynamic burden Periodic echocardiographic reassessment
Moderate or large defect with right-heart enlargement Significant volume loading possible Quantify shunt and discuss closure
Right-to-left flow with hypoxemia Elevated clinical concern Identify pressure cause and consider closure
Embolic event with demonstrable right-to-left passage Possible paradoxical embolism Multidisciplinary evaluation and secondary prevention
Complex anatomy or pulmonary hypertension Uncertain risk without hemodynamics Advanced imaging and, when needed, catheterization

Practical Follow-Up Priorities

Follow-up should be proportionate to the initial findings rather than driven by the label of “iatrogenic ASD” alone. Documenting a baseline echocardiogram after the procedure can be useful when the puncture was difficult, a large sheath was used, or the patient has pulmonary vascular or right-heart disease.

Clinicians should reassess symptoms, oxygen saturation, rhythm status, anticoagulation, and signs of right-heart strain. Repeat imaging is most informative when it answers a specific question: Has the defect closed, is the shunt clinically meaningful, or has pressure direction changed?

A practical monitoring framework includes:

Journal of Arrhythmia provides an appropriate setting for continued discussion of transseptal access, imaging standards, ablation safety, and structural complications across different patient populations. Clinicians and researchers can use its open-access evidence to refine surveillance pathways, compare procedural techniques, and identify patients who benefit from intervention rather than routine observation.